Echo Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
447.20
5.10
27.60
57.30
-
Cost of Goods Sold (COGS) incl. D&A
-
-
-
-
521.90
Gross Income
-
-
-
-
521.90
SG&A Expense
8,654.00
14,900.00
19,272.50
11,984.50
7,114.60
EBIT
8,254.70
15,040.00
19,636.50
12,319.90
7,636.40
Unusual Expense
1,764.50
3,683.70
4,466.00
911.00
9,543.80
Non Operating Income/Expense
1.40
21.30
-
0.80
4,998.80
Interest Expense
13.90
959.90
3,900.00
3,551.50
15.30
Pretax Income
10,029.60
12,332.00
19,067.40
14,958.70
22,194.40
Income Tax
-
-
-
4.00
3.40
Consolidated Net Income
10,029.60
12,332.00
19,067.40
14,962.70
22,197.90
Net Income
10,029.60
12,332.00
19,067.40
14,962.70
22,197.90
Net Income After Extraordinaries
10,029.60
12,332.00
19,067.40
14,962.70
22,197.90
Net Income Available to Common
16,722.30
12,332.00
19,438.50
15,312.70
22,197.90
EPS (Basic)
4.90
3.12
2.33
1.24
1.98
Basic Shares Outstanding
3,417.50
3,955.00
8,359.80
12,308.30
11,231.40
EPS (Diluted)
4.89
3.12
2.33
1.24
1.98
Diluted Shares Outstanding
3,417.50
3,955.00
8,359.80
12,308.30
11,231.40
EBITDA
8,206.80
14,894.90
19,244.90
11,927.20
7,114.60
Non-Operating Interest Income
4.80
5.50
3.10
1.00
-
Preferred Dividends
6,692.70
-
371.10
350.00
-
About Echo Therapeutics
View Profile
